DE69839921D1 - Verwendung von an polyamid gebundenen nukleinsäure-oligomeren zur erzeugung einer biologischen reaktion - Google Patents
Verwendung von an polyamid gebundenen nukleinsäure-oligomeren zur erzeugung einer biologischen reaktionInfo
- Publication number
- DE69839921D1 DE69839921D1 DE69839921T DE69839921T DE69839921D1 DE 69839921 D1 DE69839921 D1 DE 69839921D1 DE 69839921 T DE69839921 T DE 69839921T DE 69839921 T DE69839921 T DE 69839921T DE 69839921 D1 DE69839921 D1 DE 69839921D1
- Authority
- DE
- Germany
- Prior art keywords
- pna oligomers
- materials
- biological response
- oligomers
- provides methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3181—Peptide nucleic acid, PNA
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/953,269 US6472209B1 (en) | 1997-10-17 | 1997-10-17 | Using polyamide nucleic acid oligomers to engender a biological response |
US09/016,685 US6743627B1 (en) | 1997-10-17 | 1998-01-30 | Using polyamide nucleic acid oligomers to engender a biological response |
US16851998A | 1998-10-08 | 1998-10-08 | |
US09/168,714 US6989270B1 (en) | 1997-10-17 | 1998-10-08 | Using polyamide nucleic acid oligomers to engender a biological response |
US09/168,791 US6723560B2 (en) | 1998-10-08 | 1998-10-08 | Using polyamide nucleic acid oligomers to engender a biological response |
PCT/US1998/021888 WO1999020643A1 (en) | 1997-10-17 | 1998-10-16 | Using polyamide nucleic acid oligomers to engender a biological response |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69839921D1 true DE69839921D1 (de) | 2008-10-02 |
Family
ID=27533701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69839921T Expired - Fee Related DE69839921D1 (de) | 1997-10-17 | 1998-10-16 | Verwendung von an polyamid gebundenen nukleinsäure-oligomeren zur erzeugung einer biologischen reaktion |
Country Status (12)
Country | Link |
---|---|
US (1) | US6989270B1 (de) |
EP (1) | EP1042349B1 (de) |
JP (1) | JP2003523307A (de) |
AT (1) | ATE405575T1 (de) |
AU (1) | AU741246B2 (de) |
BR (1) | BR9814866A (de) |
CA (1) | CA2306731A1 (de) |
DE (1) | DE69839921D1 (de) |
DK (1) | DK1042349T3 (de) |
ES (1) | ES2312192T3 (de) |
IL (1) | IL135705A0 (de) |
WO (1) | WO1999020643A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6723560B2 (en) | 1998-10-08 | 2004-04-20 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
US6472209B1 (en) | 1997-10-17 | 2002-10-29 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
US6989270B1 (en) | 1997-10-17 | 2006-01-24 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5470974A (en) | 1985-03-15 | 1995-11-28 | Neu-Gene Development Group | Uncharged polynucleotide-binding polymers |
DE3687030T2 (de) | 1985-03-15 | 1993-03-11 | James Summerton | Stereoregulare polynukleotiden bindende polymere. |
US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
US5783682A (en) | 1990-07-27 | 1998-07-21 | Isis Pharmaceuticals, Inc. | Oligonucleotide mimics having nitrogen-containing linkages |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5641625A (en) | 1992-05-22 | 1997-06-24 | Isis Pharmaceuticals, Inc. | Cleaving double-stranded DNA with peptide nucleic acids |
US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
DK51092D0 (da) | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
AU7559894A (en) | 1993-08-05 | 1995-02-28 | Isis Pharmaceuticals, Inc. | Oligomers for modulating metabolic function |
WO1995004748A1 (en) | 1993-08-09 | 1995-02-16 | Isis Pharmaceuticals, Inc. | Oligomers for modulating viral processes |
US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
GB2284209A (en) | 1993-11-25 | 1995-05-31 | Ole Buchardt | Nucleic acid analogue-induced transcription of RNA from a double-stranded DNA template |
US5703067A (en) * | 1995-05-08 | 1997-12-30 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
AU5856596A (en) | 1995-05-10 | 1996-11-29 | Isis Pharmaceuticals, Inc. | Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion |
US6015710A (en) | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
GB9608803D0 (en) | 1996-04-27 | 1996-07-03 | Univ Newcastle | Mitochondrial dna defects |
CA2291839A1 (en) | 1997-05-28 | 1998-12-03 | Peter E. Nielsen | Conjugated peptide nucleic acids having enhanced cellular uptake |
WO1999005302A1 (en) | 1997-07-24 | 1999-02-04 | The Perkin-Elmer Corporation | Conjugates of transporter peptides and nucleic acid analogs, and their use |
US6300318B1 (en) | 1997-09-16 | 2001-10-09 | Peter E. Nielsen | Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
CA2303908A1 (en) | 1997-09-18 | 1999-03-25 | Gene Therapy Systems, Inc. | Chemical modification of dna using peptide nucleic acid conjugates |
US6472209B1 (en) * | 1997-10-17 | 2002-10-29 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
US6989270B1 (en) | 1997-10-17 | 2006-01-24 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
-
1998
- 1998-10-08 US US09/168,714 patent/US6989270B1/en not_active Expired - Fee Related
- 1998-10-16 IL IL13570598A patent/IL135705A0/xx unknown
- 1998-10-16 BR BR9814866-4A patent/BR9814866A/pt not_active IP Right Cessation
- 1998-10-16 CA CA002306731A patent/CA2306731A1/en not_active Abandoned
- 1998-10-16 JP JP2000516984A patent/JP2003523307A/ja active Pending
- 1998-10-16 EP EP98953610A patent/EP1042349B1/de not_active Expired - Lifetime
- 1998-10-16 AU AU10940/99A patent/AU741246B2/en not_active Ceased
- 1998-10-16 AT AT98953610T patent/ATE405575T1/de not_active IP Right Cessation
- 1998-10-16 WO PCT/US1998/021888 patent/WO1999020643A1/en active IP Right Grant
- 1998-10-16 ES ES98953610T patent/ES2312192T3/es not_active Expired - Lifetime
- 1998-10-16 DK DK98953610T patent/DK1042349T3/da active
- 1998-10-16 DE DE69839921T patent/DE69839921D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU741246B2 (en) | 2001-11-29 |
BR9814866A (pt) | 2001-11-20 |
AU1094099A (en) | 1999-05-10 |
US6989270B1 (en) | 2006-01-24 |
ES2312192T3 (es) | 2009-02-16 |
WO1999020643A9 (en) | 1999-08-05 |
IL135705A0 (en) | 2001-05-20 |
EP1042349A1 (de) | 2000-10-11 |
CA2306731A1 (en) | 1999-04-29 |
ATE405575T1 (de) | 2008-09-15 |
WO1999020643A1 (en) | 1999-04-29 |
DK1042349T3 (da) | 2008-11-10 |
EP1042349B1 (de) | 2008-08-20 |
JP2003523307A (ja) | 2003-08-05 |
EP1042349A4 (de) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE246361T1 (de) | Verfahren zur bestimmung von ige | |
DE69735445D1 (de) | Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung | |
SE0003286D0 (sv) | Method and kit for human identification | |
ATE335845T1 (de) | Elektrophoretische analyse von molekülen mit immobilisierten sonden | |
DE69813158T2 (de) | Assays zur Bestimmung von Proteinfragmenten in biologischen Medien | |
ATE529509T1 (de) | Selektion von proteinen unter verwendung von rna- protein-fusionen | |
DE60029092D1 (de) | Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen | |
DK1044374T3 (da) | Glucosebiosensor | |
DE60035691D1 (de) | Verfahren zur Erkennung von Einzel-Nukleotid-Polymorphismen | |
ATE21173T1 (de) | Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen. | |
Giller | The natural diet of the Notonectidae: field trials using electrophoresis | |
DE69422339T2 (de) | Verfahren zur Nachweis von Marijuana in einer Haar Probe | |
ATE309333T1 (de) | Synthetische polynukleotide | |
ATE318930T1 (de) | Nukleinsäuresonden zur detektion von candida- spezies | |
ATE321886T1 (de) | Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe | |
DE59408917D1 (de) | Verfahren zur identifizierung von menschlichen und tierischen zellen mit der fähigkeit zu unbegrenzter proliferation oder zur tumorbildung | |
DE60137322D1 (de) | Verbesserungen in bezug auf die analyse von dns-proben | |
DE69839921D1 (de) | Verwendung von an polyamid gebundenen nukleinsäure-oligomeren zur erzeugung einer biologischen reaktion | |
DE59814359D1 (de) | Mikrostrukturierter biosensor, verwendung des biosensors und verfahren zur immobilisierung von biokatalysatoren | |
EP0990901A3 (de) | Computergestützte Identifizierung von Paraproteinen | |
EP0809103A3 (de) | Stabile Denaturierungsmittel für elektroforetische Techniken und dafür geeignete Verfahren | |
AU4981093A (en) | Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof | |
DE69429428T2 (de) | Methode zur analyse des dna-gehalts von tumorzellen mittels tumorzellenanreicherung | |
DE69531505D1 (de) | Verfahren zur zellerkennung | |
ATE230033T1 (de) | Verwendung von primern für universelle fingerprint-analysen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |